全胸腔镜下肺叶切除术与传统开胸肺叶切除术治疗非小细胞肺癌对比研究

目的：探讨全胸腔镜下肺叶切除术与传统开胸肺叶切除术治疗非小细胞肺癌的效果。方法整群抽取2014年1月—2015年12月该院接收的62例非小细胞肺癌患者，根据手术方式分为观察组与对照组，各31例。观察组行全胸腔镜下肺叶切除术，对照组行传统开胸肺叶切除术，对比两组淋巴结清扫情况和不良反应发生率。结果观察组纵隔淋巴结及肺门、叶间淋巴结清扫个数为（250.1±1.8）个、（206.2±4.1）个，对照组为（249.3±2.1）个、（205.7±9.6）个，两组对比差异无统计学意义（P>0.05）；观察组不良反应发生率为6.45%（2/31），对照组为32.26%（10/31），两组对比差异有统计学意义（P<0.05）。结论采用全胸腔镜下肺叶切除术治疗非小细胞肺癌效果显著，患者术后恢复快、创伤小，且不良反应发生率低。

Comparative Study of Full Ehoracoscopic Lobectomy and the Traditional Thoracotomy Lobectomy in the Treatment of Non-small Cell Lung Cancer

Objective To explore the effect of full thoracoscopic lobectomy and the traditional thoracotomy lobectomy in the treatment of non-small cell lung cancer. Methods Group selection 62 patients with non small cell lung cancer received in our hospital from January 2014 to December 2015 were divided into observation group and control group, 31 cases in each group. Observation group used total thoracoscopic lobectomy; the control group used thoracotomy. lymph node dissection cases and incidence of adverse reactions of the two groups were compared. Results In the observation group, the number of Hilar and mediastinal lymph node and Mesenchymal lymphadenectomy are (250.1 ± 1.8)and (206.2 ± 4.1) ; The control group (249.3 ± 2.1) and (205.7 ± 9.6);there was no significant difference between two groups (P>0.05); Adverse reactions of the observation group was 6.45% (2/31); in the control group it was 32.26% (10/31).when compared the two groups, there was significant difference (P<0.05). Conclusion The non small cell lung cancer lobectomy for thoracoscopic effect is re-markable, with faster postoperative recovery, less trauma, and adverse reaction rate is low.